HLA-C and neoplasm: As shown in previous studies, due to its dual specificity for CD3 and PSCA it can specifically cross-link T cells and PSCA-expressing tumor cells in a MHC- and TCR-independent manner that finally culminates in effective tumor cell elimination (Feldmann et al., 2012).